PLEUROPULMONARY CHANGES DURING LONG-TERM BROMOCRIPTINE TREATMENT FOR PARKINSON'S DISEASE
- 3 January 1981
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 317 (8210) , 44-45
- https://doi.org/10.1016/s0140-6736(81)90150-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- RECENT ADVANCES IN THE TREATMENT OF PARKINSON'S DISEASEActa Neurologica Scandinavica, 1980
- Long‐term efficacy of bromocriptine in Parkinson diseaseNeurology, 1980
- Brain dopamine receptor stimulation and the relief of parkinsonism: Relationship between bromocriptine and levodopaAnnals of Neurology, 1978
- LONG-TERM TREATMENT OF PARKINSONISM WITH BROMOCRIPTINEThe Lancet, 1978
- Brain Dopamine Turnover and the Relief of ParkinsonismArchives of Neurology, 1977
- IDIOPATHIC PARKINSONISM TREATED WITH BROMOCREPTINEThe Lancet, 1975
- Bromocriptine in ParkinsonismBMJ, 1974
- Pleural Effusion and Fibrosis Secondary to Sansert AdministrationThe Annals of Thoracic Surgery, 1973
- Pleural Effusion and Fibrosis during Treatment with MethysergideBMJ, 1970
- Fibrotic Disorders Associated with Methysergide Therapy for HeadacheNew England Journal of Medicine, 1966